Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Janssen-Cilag EMEA Medical Affairs
Woman and Man Max 99 years
Janssen-Cilag EMEA Medical Affairs
Update Il y a 5 ans
A Phase II, Multicentre, Randomised, Open-Label, Parallel Group Study to Evaluate the Safety and Efficacy of Velcade® added to Thalidomide-Dexamethasone Standard Treatment in Subjects with Multiple Myeloma who are Refractory to or Have Relapsed after Primary Therapy for Multiple Myeloma
to assess the safety and efficacy of adding Velcade® to thalidomide and dexamethasone (Thal-Dex) standard treatment in subjects with multiple myeloma who are refractory to or have relapsed after thei...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Janssen-Cilag EMEA Medical Affairs
Update Il y a 5 ans
Comparación de fentanilo transdérmico y morfina intravenosa en analgesia controlada por el paciente para el control del dolor postoperatorio
Aim of this study This study will evaluate the clinical use, safety and and ease of care of a Transdermal PCA system and morphine IV PCA for management of moderate to severe acute pain in post?operati...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Janssen-Cilag EMEA Medical Affairs
Update Il y a 5 ans
Velcade bone trial
The primary objective is to assess the effect of bortezomib on myeloma related bone disease by analyzing bone mineral density (BMD).
Country
None
organs
None
Specialty
None
Closed trial
More information